Skip to main content
Erschienen in: Hepatology International 5/2020

04.09.2020 | COVID-19 | Original Article Zur Zeit gratis

Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury

verfasst von: Ping Lei, Lan Zhang, Ping Han, Chuansheng Zheng, Qiaoxia Tong, Haitao Shang, Fan Yang, Yu Hu, Xin Li, Yuhu Song

Erschienen in: Hepatology International | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Liver injury is found in some of patients with COVID-19. Liver injury of COVID-19 patients based on severity grading and abdominal radiological signs have not been reported until now. The aim of our study is to determine clinical profiles of the patients based on severity grading, describe abdominal radiological signs, and investigate the correlations of the severity with clinical profiles and radiological signs.

Methods

This retrospective cohort study included 115 patients with COVID-19 from Jan 2020 to Feb 2020. Medical records of the patients were collected and CT images were reviewed.

Results

Common clinical manifestations of patients with COVID-19 were fever (68.70%), cough (56.52%), fatigue (31.30%); some of them had gastrointestinal symptoms (diarrhea, 12.17%; nausea or vomiting 7.83%; inappetence, 7.83%). Abnormal liver function was observed in some of patients with COVID-19. Significant differences in the levels of AST, albumin,CRP were observed among different groups classified by the severity. Common findings of upper abdominal CT scan were liver hypodensity (26.09%) and pericholecystic fat stranding (21.27%); liver hypodensity was more frequently found in critical cases (58.82%). The severity of COVID-19 correlated with semi-quantitative CT score of pulmonary lesions, CT-quantified liver/spleen attenuation ratio in patients with COVID-19.

Conclusions

Some of the patients with COVID-19 displayed liver damage revealed by liver functional tests and upper abdominal CT imaging, and the severity of COVID-19 patients correlated with some of liver functional tests and CT signs; thus, it will allow an earlier identification of high-risk patients for early effective intervention.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–513.CrossRefPubMedPubMedCentral Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507–513.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med 2020;8:e17.PubMedPubMedCentral Rismanbaf A, Zarei S. Liver and kidney injuries in COVID-19 and their effects on drug therapy; a letter to editor. Arch Acad Emerg Med 2020;8:e17.PubMedPubMedCentral
8.
9.
Zurück zum Zitat Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1722.CrossRefPubMed Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1722.CrossRefPubMed
13.
17.
Zurück zum Zitat Kan X, Ye J, Rong X, et al. Diagnostic performance of contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep 2016;6:37998.CrossRefPubMedPubMedCentral Kan X, Ye J, Rong X, et al. Diagnostic performance of contrast-enhanced CT in pyrrolizidine alkaloids-induced hepatic sinusoidal obstructive syndrome. Sci Rep 2016;6:37998.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Li X, Yang X, Xu D, et al. Magnetic resonance imaging findings in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Clin Gastroenterol Hepatol 2017;15:955–957.CrossRefPubMed Li X, Yang X, Xu D, et al. Magnetic resonance imaging findings in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome. Clin Gastroenterol Hepatol 2017;15:955–957.CrossRefPubMed
19.
Zurück zum Zitat Guo T, Li X, Yang X, et al. Gadoxetic acid-enhanced hepatobiliary-phase magnetic resonance imaging for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome and association with liver function. Sci Rep 2019;9:1231.CrossRefPubMedPubMedCentral Guo T, Li X, Yang X, et al. Gadoxetic acid-enhanced hepatobiliary-phase magnetic resonance imaging for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome and association with liver function. Sci Rep 2019;9:1231.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Chang Y-C, Yu C-J, Chang S-C, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome evaluation with thin section CT. Radiology 2005;236:1067–1075.CrossRefPubMed Chang Y-C, Yu C-J, Chang S-C, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome evaluation with thin section CT. Radiology 2005;236:1067–1075.CrossRefPubMed
22.
Zurück zum Zitat Zeb I, Li D, Nasir K, et al. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012;19:811–818.CrossRefPubMedPubMedCentral Zeb I, Li D, Nasir K, et al. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012;19:811–818.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130:2620–2629.CrossRefPubMedPubMedCentral Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020;130:2620–2629.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020;135:2033–2040.CrossRefPubMed Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020;135:2033–2040.CrossRefPubMed
Metadaten
Titel
Liver injury in patients with COVID-19: clinical profiles, CT findings, the correlation of the severity with liver injury
verfasst von
Ping Lei
Lan Zhang
Ping Han
Chuansheng Zheng
Qiaoxia Tong
Haitao Shang
Fan Yang
Yu Hu
Xin Li
Yuhu Song
Publikationsdatum
04.09.2020
Verlag
Springer India
Erschienen in
Hepatology International / Ausgabe 5/2020
Print ISSN: 1936-0533
Elektronische ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-020-10087-1

Weitere Artikel der Ausgabe 5/2020

Hepatology International 5/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.